Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
PERSERIS™
(risperidone) for extended-release injectable suspension
ZULRESSO™
(brexanolone) injection CIV
You are here
Home
News by month %2 2013
News by month October 2013
PTCommunity News October 2013
‘Intensive' Exercise May Help Patients With Heart Failure
FDA Outlines Plan to Combat Drug Shortages
CDC Report: U.S. Malaria Cases Reach 40-Year High
Boxed Warning Added to Ezogabine (Potiga) Label
FDA Approves Leukemia Drug Obinutuzumab (Gazyva)
Pre-Hospital Bivalirudin Improves Outcomes Compared With Heparin in Heart Attack Patients
Report: SLE Drug Market Will Grow Dramatically Over Next Decade
FDA Agrees to Review Insulin Inhalation Powder, Afrezza
Congressional Committees Offer Plan to Fix Medicare Doctor Payments
Ovarian Cancer Drug Fails Mid-Stage Trial
Gallup Poll: Views of Affordable Care Act Remain Steady
Affordable Care Act Could Reverse Long Trend of Uncompensated Care in ERs
FDA Okays Long-Acting Painkiller, Zohydro ER
Exhaled Breath Biomarker May Detect Lung Cancer
Positive 2-Year Data Reported for Simponi Aria (Golimumab) in Active RA
FDA Expands Sabril (Vigabatrin) Indication to Include Children With Partial Seizures
CDC Reports Trends in Cholesterol Levels of U.S. Adults
FDA Approves Addition to Cialis (Tadalafil) Label
FDA to Complete Phase-Out of Chlorofluorocarbon Inhalers
Simple Blood Test May Catch Early Pancreatic Cancer
Imaging Breast Cancer With Light
Single-Tablet HIV Regimen Submitted for FDA Review
‘Complete Care’ Approach Improves Patient Outcomes
Endocrinology Groups Issue Top Five Recommendations
Phase III Program Evaluates Selumetinib in Lung Cancer
One-Third of U.S. Adults Are Obese, CDC Finds
Ariad Pharma Discontinues Phase III Trial of Ponatinib (Iclusig) in Leukemia Patients
FDA Approves Cimzia (Certolizumab Pegol) for Ankylosing Spondylitis
New Ovarian Cancer Treatment Succeeds in Lab
Positive Phase III Results Reported for Abraxane (Paclitaxel) in Metastatic Pancreatic Cancer
FDA Approves Coagulation Drug NovoEight (Turoctocog Alfa)
Stribild, Single-Tablet HIV Regimen, Demonstrates Long-Term Viral Suppression
Generic Tobi (Tobramycin) Gets FDA Nod
FDA Approves Otrexup (Methotrexate) Injection for Arthritis and Psoriasis
Report Cards for Hospital-Acquired Bedsores: How Good Are the Grades?
National Survey: Low Public Awareness of <i>BRCA</i> Testing for Risk of Inherited Breast and Ovarian Cancers
Diabetes Drug Afrezza (Insulin Inhalation Powder) Resubmitted for FDA Review
Study: Chronic Pain Treatment Relieves Hot Flashes in Menopausal Women
Positive Data Reported for Subcutaneous Ofatumumab in Multiple Sclerosis
Stem-Cell Capsules for Heart Therapy
Report Outlines Steps to Manage High-Cost Specialty Drugs as Costs Rise
Phase III Trials Evaluate New Add-On Treatment for Alzheimer’s Disease
Positive Phase III Results Reported for Idelalisib in Leukemia Patients
Report: Ulcerative Colitis Drug Market Will Increase From $2.1 Billion in 2012 to $3.6 Billion in 2022
Tofacitinib Shows Mixed Results in Adults With Plaque Psoriasis
Does ‘Good’ Cholesterol Increase Breast Cancer Risk?
FDA Approves Adempas (Riociguat) for Pulmonary Hypertension
Physician Job Satisfaction Driven by Quality of Patient Care
Survey: Physicians Likely to Use High-Priced Antibiotics for Drug-Resistant Infections
FDA Agrees to Review Hyperphosphatemia Drug, Zerenex (Ferric Citrate)
Sickle Cells Deliver Chemotherapy in New Cancer Treatment
Why Do Some Doctors Abuse Prescription Drugs?
Breast Health Device Recalled
Experimental Vaccine Reduces Norovirus Symptoms
Updated Recommendations on Youth Blood Pressure Screening
New Compounds Show Promise for Anti-Flu Medicines
Fingolimod (Gilenya) Reduces Brain Volume Loss in MS Patients
High Medicare Spending on Prostate Cancer Screenings, But Little Benefit for Older Men
Humira (Adalimumab) Shows Promise in Patients With Inflammatory Skin Disease
Sublingual Fentanyl (Abstral) Launched in U.S. for Treatment of Breakthrough Cancer Pain
Ramucirumab Improves Survival in Gastric Cancer Patients
New Classification Criteria for Systemic Sclerosis
Better Patient Outcomes With Dabigatran (Pradaxa) Versus Warfarin in Phase III Trials
Report: Multiple Sclerosis Cases Have Increased 10% in Past 5 Years
Generic Zemplar (Paricalcitol) Launched in U.S.
Blood-Pressure Drug May Help Improve Cancer Treatment
Treatment Trends in Type 2 Diabetes
FDA Announces the Use of New Electronic Drug Labels To Help Better Inform the Public, Improve Patient Safety
Emerging Staph Strains Found To Be Increasingly Deadly and Deceptive
Experimental Shingles Vaccine Proves Effective in Nationwide Study
